The therapeutic efficacy of Xuan-Fei Bai-Du decoction in the treatment of novel coronavirus pneumonia (COVID-19): a pilot randomized controlled trial

Wuhan Hospital of Traditional Chinese Medicine0 个研究点开始时间: 待定最近更新: 2023年2月20日

适应症

试验速览

暂无简介。

•1. Inpatients in Wuhan Pulmonary Hospital (from January 30 to February 10, 2020) who meet the diagnostic criteria of COVID-19;
•2. Aged 18-75 years old;
•3. According to the fourth edition of guideline, meeting the mild and severe standards;
•4. Agreeing to participate in the trial;
•5. No antibiotics were used during one cycle of this treatment.

•1. According to the fourth edition of guideline, meeting the critical standard;
•2. Acute respiratory diseases not caused by 2019-nCoV;
•3. Asthma patients who need daily treatment;
•4. Severe lung interstitial lesions, bronchiectasis and other basic lung disease patients;
•5. Accompanied by severe primary immunodeficiency disease, acquired immunodeficiency syndrome, congenital respiratory malformations, congenital heart disease, abnormal lung development and other basic diseases;
•6. pregnant women.

发起方

Wuhan Hospital of Traditional Chinese Medicine